Legend Biotech to Participate in the Jefferies Global Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- Houthi strike on Saudi airport kills 12, worst attack on kingdom in a decade
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
Citi Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
May 31, 2024 5:30 AM EDTCiti analyst Wangbin Zhou reiterated a Buy rating and $95.00 price target on Legend Biotech Corp. (NASDAQ: LEGN)
The analyst comments "We had an update call with LEGN and they reiterated 2H24 sales growth, driven by on-track capacity ramp-up and 2-4L launch. Mgmt.... More



